MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
about
Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencingThe Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaThe miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionThe role of miRNAs in cutaneous squamous cell carcinomaEvaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic PotentialOver-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of β-cateninA genome-wide search for loci interacting with known prostate cancer risk-associated genetic variantsThe expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinomaCirculating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.Targeting miRNAs for pancreatic cancer therapyMolecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury.Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancerMiR-467a is upregulated in radiation-induced mouse thymic lymphomas and regulates apoptosis by targeting Fas and Bax.MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3.Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreasSmad-mediated regulation of microRNA biosynthesis.Oridonin alters the expression profiles of microRNAs in BxPC-3 human pancreatic cancer cells.Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypesIntegrated microRNA and mRNA responses to acute human left ventricular ischemia.Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) modelPrediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.Novel strategies targeting cancer stem cells through phytochemicals and their analogsmiRNA: The nemesis of gastric cancer (Review).Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.Pancreatic cancer diagnosis by free and exosomal miRNA.While at Rome miRNA and TRAIL do whatever BCR-ABL commands to do.miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.Developments in miRNA gene signaling pathways in pancreatic cancer.miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection.CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest.
P2860
Q21134708-B88FBABE-BF1F-457A-AD9E-02B332A39F3DQ26744298-BD899544-BB84-4262-B00A-DED6A3A62964Q26744831-30D405E1-3045-4421-B9A3-7B31591CCAC0Q26778339-2678CEFB-FE2E-4943-ABE8-F9E8F2767D41Q28084310-5ED61223-BB2B-400E-B486-91776B1320CBQ28385613-67102B7F-75A9-414B-A766-8CCC929F4786Q28943269-9D046C94-F5DF-4433-9AC6-CE72A1DC7128Q33579675-CA76433F-04AC-4062-A85B-0895E37BE6B7Q33687038-B632AD8D-0298-4199-ACDB-AD3A36FBB467Q33733403-39A428FC-DC97-4FAD-943C-2E413AF6F114Q33948361-42DFD4D7-8CE9-4587-8428-053EB9CBF090Q33962488-65F07BEA-ED52-47CC-8E69-99F8E2B9974DQ34177065-A3D3AF06-151D-43FF-B049-20B960717301Q34479270-AADDA73A-9867-42C8-9B4B-3288747CB2C5Q34648569-6A62E5C0-A51B-495E-BC53-E5009CAEC6F8Q34775829-0A5B2896-7E10-4441-ADFD-FE5DCC5637E5Q34780990-516D6328-C371-4A4C-B855-7C5B36F87705Q34791957-53B5BD75-D005-44B2-9C98-4E8012CF268EQ34805242-740EF4A1-B6CC-41C5-A7AD-E306FDB05BEBQ35450240-DC8E26DE-128F-4D7D-9635-1F49BC370F90Q35600535-D16F75EA-C354-49BE-96AD-0CCB95AE7F24Q35604232-969520F2-74E4-48DE-AB58-E5567ADBE8E6Q35735278-AF54542E-97E5-48CE-89A2-2FF99A0AF282Q35862870-59877ABC-47C1-4FB0-9618-FA2EB61572FCQ36122833-022576C2-1C40-4159-BB00-3FE520726CAAQ36275017-327C3F90-E6FC-451D-BD2D-6D9811BD3EE9Q36545604-D381EDDF-9D54-4E99-B079-CD30EDDF1BD7Q36889793-154B6A4A-0E93-4D49-8164-B4EC1C9E2A6CQ37198168-C8890D3F-2936-486E-9DCD-89D27FB3554EQ37211784-8E1C4209-15F9-42D3-A3FF-0520B9638DEAQ37218051-1A34DE3E-21B9-4D54-AE6D-70C841D26146Q37382231-21F7755B-D26A-4891-9711-8357CDCC6C91Q38066406-97BAC756-A6BB-4DE5-88C7-5274A54A12F6Q38383813-3A55488C-E6CA-4A36-83CC-26DCF199003EQ38777530-6B06DFA4-63C1-4DE6-B78C-4B4106586E56Q38800321-DA9F6B41-92F2-479E-A9F9-053E12343E75Q38858750-F03F7184-5691-4624-8F14-438E2840EEA5Q39038680-7B26446D-0074-4020-A51E-29D6B3493C05Q40488170-9696C7FD-896A-42B8-8C3B-0DFFA420F287Q40497578-4B333425-6C9D-4420-B022-390EF0865C65
P2860
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
@en
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
@nl
type
label
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
@en
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
@nl
prefLabel
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
@en
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
@nl
P2093
P2860
P1433
P1476
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
@en
P2093
Chenghao Shao
Shuyu Zhang
Xiangui Hu
Yingqi Zhou
P2860
P304
P356
10.1016/J.FEBSLET.2010.11.039
P407
P577
2010-11-27T00:00:00Z